510(k) K863218
K863218 is an FDA 510(k) premarket notification submitted by Meadox Surgimed, Inc. for the device "CYTOSTATIC FILTRATION SET". The FDA issued a decision of Substantially Equivalent on February 12, 1987. The device falls under product code LFK (Catheter, Femoral), a Class II device regulated under 21 CFR 876.5540. Meadox Surgimed, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 12, 1987
- Date Received
- August 20, 1986
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Catheter, Femoral
- Device Class
- Class II
- Regulation Number
- 876.5540
- Review Panel
- GU
- Submission Type